Clinical Trial

Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy

Study acronym: TAKO MEMRI
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this research study is to further understand the physiological mechanisms involved in a heart condition called takotsubo cardiomyopathy, also known as broken heart syndrome. Furthermore, the investigators will be assessing the effects different cardiac medications have on these physiological mechanisms. This will be achieved by performing cardiac MRI scans using a special dye called manganese. Manganese uptake in the heart is altered in patients with takotsubo cardiomyopathy. The investigators will study the effects that different cardiac medications have on manganese uptake.
Trial Details
NCT Number NCT07491718
Lead Sponsor University of Edinburgh
Conditions Takotsubo Cardiomyopathy
Enrollment 100 participants
Start Date 2025-08-08
Primary Completion 2028-08-09 (estimated)
Study Completion 2028-08-09 (estimated)
Updated on ClinicalTrials.gov 2026-03-24